探讨聚乙二醇干扰素联合利巴韦林治疗慢性丙肝的护理要点

Explore the Nursing Points of Pegylated Interferon Combined With Leigh Bhave Lin in the Treatment of Chronic Hepatitis C

目的探讨和分析聚乙二醇干扰素联合利巴韦林治疗慢性丙肝的护理要点。方法选择我院2014年11月—2016年2月收治的63例慢性丙肝患者作为研究对象,全部患者均通过聚乙二醇干扰素与利巴韦林进行联合治疗,总结患者治疗效果以及护理要点。结果在63例患者中,经有效的治疗和护理之后,终点应答的例数为58例,应答率为92.06%,没有严重的毒副作用发生。结论对慢性丙肝患者通过利巴韦林与聚乙二醇干扰素进行联合治疗时,应密切观察患者用药过程中出现的毒副作用,并制定相应的护理干预措施,进行积极的防治和干预,能降低不良反应发生的风险。

Objective To investigate and analyze the nursing of pegylated interferon combined with leigh bhave lin in the treatment of chronic hepatitis C.Methods 63 cases of patients with chronic hepatitis C in our hospital from November 2014 to February 2016 as research subjects,all patients were treated by polyethylene glycol interferon and leigh bhave lin combined therapy,summarize the treatment effect and nursing points Results In 63 patients,after effective treatment and nursing,the number of cases of end point response in 58 cases,the response rate was 92.06%.No serious side effects occurred.Conclusion The combined treatment of patients with chronic hepatitis C by leigh bhave lin and pegylated interferon,should be closely observed in patients during the medication toxic and side effects,and formulate corresponding nursing intervention measures,prevention and intervention actively,can reduce the risk of adverse reactions.